Effect of female sex on cardiac arrhythmias

Cardiology in Review

Volumn 20, Issue 6, 2012, Pages 297-303

  Gowd, B M Pampana ^a   Thompson, Paul D ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

cardiac arrhythmias; Sex; sex hormones

Indexed keywords

ESTROGEN; PROGESTERONE; SEX HORMONE;

ESTROGEN BLOOD LEVEL; FEMALE; GENDER; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART PALPITATION; HEART RATE; HEART SIZE; HEART VENTRICLE ARRHYTHMIA; HUMAN; LONG QT SYNDROME; LUTEAL PHASE; MENSTRUAL CYCLE; PR INTERVAL; PREGNANCY; PREVALENCE; QRS COMPLEX; QT INTERVAL; REENTRY TACHYCARDIA; REVIEW; SUPRAVENTRICULAR TACHYCARDIA;

ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HEART RATE; HUMANS; MALE; MENOPAUSE; PREVALENCE; PROGESTERONE; RISK FACTORS; SEX FACTORS; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; UNITED STATES; WORLD HEALTH;

EID: 84867582884     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e318259294b     Document Type: Review

References (147)

1. Larsen JA, Kadish AH. Effects of gender on cardiac arrhythmias. J Cardiovasc Electrophysiol. 1998;9:655-664.
2. Bazett HC. The time relations of the blood-pressure changes after excision of the adrenal glands, with some observations on blood volume changes. J Physiol (Lond). 1920;53:320-339.
3. Rautaharju PM, Zhou SH, Wong S, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 1992;8:690-695.
4. Lehmann MH, Hardy S, Archibald D, et al. Sex difference in risk of torsade de pointes with d, l-sotalol. Circulation. 1996;94:2535-2541.
5. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fbrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840-844.
6. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fbrillation. Analysis and implications. Arch Intern Med. 1995;155:469-473.
7. Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993;270:2590-2597.
8. Kim C, Fahrenbruch CE, Cobb LA, et al. Out-of-hospital cardiac arrest in men and women. Circulation. 2001;104:2699-2703.
9. Ling S, Komesaroff P, Sudhir K. Cellular mechanisms underlying the cardiovascular actions of oestrogens. Clin Sci. 2006;111:107-118.
10. Treloar AE, Boynton RE, Behn BG, et al. Variation of the human menstrual cycle through reproductive life. Int J Fertil. 1967;12(1 Pt 2):77-126.
11. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv. 2003;3:281-292.
12. Meyer R, Linz KW, Surges R, et al. Rapid modulation of L-type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea-pig and rat. Exp Physiol. 1998;83:305-321.
13. Groh C, Stefan K, Kerstin LB et al. Cardiac myocytes and fbroblasts contain functional estrogen receptors1 Presented in part at the 67th Scientifc Sessions of the American Heart Association, Dallas, 14-17 November 1994.1. FEBS lett 1997;416:107-112.
14. Stumpf WE, Sar M, Aumüller G. The heart: a target organ for estradiol. Science. 1977;196:319-321.
15. Ropero AB, Eghbali M, Minosyan TY, et al. Heart estrogen receptor alpha: distinct membrane and nuclear distribution patterns and regulation by estrogen. J Mol Cell Cardiol. 2006;41:496-510.
16. Klinge CM. Estrogenic control of mitochondrial function and biogenesis. J Cell Biochem. 2008;105:1342-1351.
17. Coleman KM, Smith CL. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci. 2001;6:D1379-D1391.
18. Ullrich ND, Krust A, Collins P, et al. Genomic deletion of estrogen receptors ERalpha and ERbeta does not alter estrogen-mediated inhibition of Ca2+ infux and contraction in murine cardiomyocytes. Am J Physiol Heart Circ Physiol. 2008;294:H2421-H2427.
19. Furukawa T, Kurokawa J. Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias. Pharmacol Ther. 2007;115:106-115.
20. Sitzler G, Lenz O, Kilter H, et al. Investigation of the negative inotropic effects of 17 beta-oestradiol in human isolated myocardial tissues. Br J Pharmacol. 1996;119:43-48.
21. Jiang C, Poole-Wilson PA, Sarrel PM, et al. Effect of 17 beta-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol. 1992;106:739-745.
22. Eckstein N, Nadler E, Barnea O, et al. Acute effects of 17 beta-estradiol on the rat heart. Am J Obstet Gynecol. 1994;171:844-848.
23. Raddino R, Manca C, Poli E, et al. Effects of 17 beta-estradiol on the isolated rabbit heart. Arch Int Pharmacodyn Ther. 1986;281:57-65.
24. Marni F, Wang Y, Morishima M, et al. 17 beta-estradiol modulates expression of low-voltage-activated Ca(V)3.2 T-type calcium channel via extra-cellularly regulated kinase pathway in cardiomyocytes. Endocrinology. 2009;150:879-888.
25. Drici MD, Burklow TR, Haridasse V, et al. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation. 1996;94:1471-1474.
26. Hulot JS, Démolis JL, Rivière R, et al. Infuence of endogenous oestrogens on QT interval duration. Eur Heart J. 2003;24:1663-1667.
27. Johnson BD, Zheng W, Korach KS, et al. Increased expression of the cardiac L-type calcium channel in estrogen receptor-defcient mice. J Gen Physiol. 1997;110:135-140.
28. Grohé C, Kahlert S, Löbbert K, et al. Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. J Endocrinol. 1998;156:R1-R7.
29. Barrett KB, Biotano S, Edwin SB. GANONG'S Review of Medical Physiology. In: GANONG'S Review of Medical Physiology. 23 ed, New York, US. McGraw-Hill; 2010:443-444.
30. Janse de Jonge XA, Boot CR, Thom JM et al. The infuence of menstrual cycle phase on skeletal muscle contractile characteristics in humans. J Physiol. 2001;530:161-166.
31. Cutini P, Sellés J, Massheimer V. Cross-talk between rapid and long term effects of progesterone on vascular tissue. J Steroid Biochem Mol Biol. 2009;115:36-43.
32. Wen DX, Xu YF, Mais DE, et al. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol. 1994;14:8356-8364.
33. Nakamura Y, Suzuki T, Inoue T, et al. Progesterone receptor subtypes in vascular smooth muscle cells of human aorta. Endocr J. 2005;52:245-252.
34. Ingegno MD, Money SR, Thelmo W, et al. Progesterone receptors in the human heart and great vessels. Lab Invest. 1988;59:353-356.
35. Knowlton AA, Sun L. Heat-shock factor-1, steroid hormones, and regulation of heat-shock protein expression in the heart. Am J Physiol Heart Circ Physiol. 2001;280:H455-H464.
36. Welter BH, Hansen EL, Saner KJ, et al. Membrane-bound progesterone receptor expression in human aortic endothelial cells. J Histochem Cytochem. 2003;51:1049-1055.
37. Mendiberri J, Rauschemberger MB, Selles J, et al. Involvement of phos-phoinositide-3-kinase and phospholipase C transduction systems in the non-genomic action of progesterone in vascular tissue. Int J Biochem Cell Biol. 2006;38:288-296.
38. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol. 1991;261(4 Pt 2):R1022-R1027.
39. Hanke H, Hanke S, Bruck B, et al. Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis. Atherosclerosis. 1996;121:129-138.
40. Skafar DF, Xu R, Morales J, et al. Clinical review 91: Female sex hormones and cardiovascular disease in women. J Clin Endocrinol Metab. 1997;82:3913-3918.
41. Chen F P, Lee N, Soong YK. Changes in the lipoprotein profle in postmeno-pausal women receiving hormone replacement therapy. Effects of natural and synthetic progesterone. J Reprod Med. 1998;43:568-574.
42. Nakagawa M, Ooie T, Takahashi N, et al. Infuence of menstrual cycle on QT interval dynamics. Pacing Clin Electrophysiol. 2006;29:607-613.
43. Rodriguez I, Kilborn MJ, Liu XK, et al. Drug-induced QT prolongation in women during the menstrual cycle. JAMA. 2001;285:1322-1326.
44. Nakamura H, Kurokawa J, Bai CX, et al. Progesterone regulates cardiac repo-larization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation. 2007;116:2913-2922.
45. Yang PC, Kurokawa J, Furukawa T, et al. Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation study. PLoS Comput Biol. 2010;6:e1000658.
46. Bidoggia H, Maciel J P, Capalozza N, et al. Sex differences on the electrocar-diographic pattern of cardiac repolarization: possible role of testosterone. Am Heart J. 2000;140:678-683.
47. Burke JH, Ehlert FA, Kruse JT, et al. Gender-specifc differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol. 1997;79:178-181.
48. Merri M, Benhorin J, Alberti M, et al. Electrocardiographic quantitation of ventricular repolarization. Circulation. 1989;80:1301-1308.
49. BYER E, ASHMAN R, TOTH LA. Electrocardiograms with large, upright T waves and long Q-T intervals. Am Heart J. 1947;33:796-806.
50. Levinson S, Liu K, Stamler J, et al. Ethnic differences in blood pressure and heart rate of Chicago school children. Am J Epidemiol. 1985;122:366-377.
51. Jose AD, Taylor RR. Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest. 1969;48:2019-2031.
52. Jose AD, Collison D. The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res. 1970;4:160-167.
53. Burke JH, Goldberger JJ, Ehlert FA, et al. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med. 1996;100:537-543.
54. Bailey MS, Curtis AB. The effects of hormones on arrhythmias in women. Curr Womens Health Rep. 2002;2:83-88.
55. Malik M, Bigger JT, Camm AJ et al. Heart rate variability. Eur Heart J. 1996;17:354-381.
56. Kleiger RE, Miller J P, Bigger JT Jr, et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256-262.
57. Tsuji H, Venditti FJ Jr, Manders ES, et al. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation. 1994;90:878-883.
58. Schwartz JB, Gibb WJ, Tran T. Aging effects on heart rate variation. J Geron-tol. 1991;46:M99-106.
59. Liao D, Barnes RW, Chambless LE, et al. Age, race, and sex differences in autonomic cardiac function measured by spectral analysis of heart rate variability-the ARIC study. Atherosclerosis Risk in Communities. Am J Car-diol. 1995;76:906-912.
60. Huikuri H V, Pikkujämsä SM, Airaksinen KE, et al. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation. 1996;94:122-125.
61. Gregoire J, Tuck S, Yamamoto Y, et al. Heart rate variability at rest and exercise: infuence of age, gender, and physical training. Can J Appl Physiol. 1996;21:455-470.
62. Bigger JT Jr, Fleiss JL, Steinman RC, et al. RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation. 1995;91:1936-1943.
63. Yeragani VK, Sobolewski E, Kay J, et al. Effect of age on long-term heart rate variability. Cardiovasc Res. 1997;35:35-42.
64. Leicht AS, Hirning DA, Allen GD. Heart rate variability and endogenous sex hormones during the menstrual cycle in young women. Exp Physiol. 2003;88:441-446.
65. Liu CC, Kuo TB, Yang CC. Effects of estrogen on gender-related auto-nomic differences in humans. Am J Physiol Heart Circ Physiol. 2003; 285:H2188-H2193.
66. Princi T, Parco S, Accardo A, et al. Parametric evaluation of heart rate variability during the menstrual cycle in young women. Biomed Sci Instrum. 2005;41:340-345.
67. Tanaka M, Sato M, Umehara S, et al. Infuence of menstrual cycle on baro-refex control of heart rate: comparison with male volunteers. Am J Physiol Regul Integr Comp Physiol. 2003;285:R1091-R1097.
68. Saeki Y, Atogami F, Takahashi K, et al. Refex control of autonomic function induced by posture change during the menstrual cycle. J Auton Nerv Syst. 1997;66:69-74.
69. Sato N, Miyake S, Akatsu J, et al. Power spectral analysis of heart rate variability in healthy young women during the normal menstrual cycle. Psychosom Med. 1995;57:331-335.
70. McKinley PS, King AR, Shapiro PA, et al. The impact of menstrual cycle phase on cardiac autonomic regulation. Psychophysiology. 2009;46:904-911.
71. Guasti L, Grimoldi P, Mainardi LT, et al. Autonomic function and barore-fex sensitivity during a normal ovulatory cycle in humans. Acta Cardiol. 1999;54:209-213.
72. Yildirir A, Kabakci G, Akgul E, et al. Effects of menstrual cycle on cardiac autonomic innervation as assessed by heart rate variability. Ann Noninvasive Electrocardiol. 2002;7:60-63.
73. Brockbank CL, Chatterjee F, Bruce SA, et al. Heart rate and its variability change after the menopause. Exp Physiol. 2000;85:327-330.
74. Hirshoren N, Tzoran I, Makrienko I, et al. Menstrual cycle effects on the neurohumoral and autonomic nervous systems regulating the cardiovascular system. J Clin Endocrinol Metab. 2002;87:1569-1575.
75. Christ M, Seyffart K, Tillmann HC, et al. Hormone replacement in postmeno-pausal women: impact of progestogens on autonomic tone and blood pressure regulation. Menopause. 2002;9:127-136.
76. Rosano GM, Leonardo F, Sarrel PM, et al. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet. 1996;347:786-788.
77. Myerburg RJ, Cox MM, Interian A Jr, et al. Cycling of inducibility of paroxysmal supraventricular tachycardia in women and its implications for timing of electrophysiologic procedures. Am J Cardiol. 1999;83:1049-1054.
78. Fleg JL, Das DN, Wright J, et al. Age-associated changes in the components of atrioventricular conduction in apparently healthy volunteers. J Gerontol. 1990;45:M95-100.
79. Taneja T, Mahnert BW, Passman R, et al. Effects of sex and age on electrocar-diographic and cardiac electrophysiological properties in adults. Pacing Clin Electrophysiol. 2001;24:16-21.
80. Macfarlane P W, McLaughlin SC, Devine B, et al. Effects of age, sex, and race on ECG interval measurements. J Electrocardiol. 1994;27 Suppl:14-19.
81. Smetana P, Batchvarov VN, Hnatkova K, et al. Sex differences in repolariza-tion homogeneity and its circadian pattern. Am J Physiol Heart Circ Physiol. 2002;282:H1889-H1897.
82. Liu S, Yuan S, Kongstad O, et al. Gender differences in the electrophysiologi-cal characteristics of atrioventricular conduction system and their clinical implications. Scand Cardiovasc J. 2001;35:313-317.
83. Collins P, Rosano GM, Jiang C, et al. Cardiovascular protection by oestro-gen-A calcium antagonist effect? Lancet. 1993;341:1264-1265.
84. Hara M, Danilo P Jr, Rosen MR. Effects of gonadal steroids on ventricular repolarization and on the response to E4031. J Pharmacol Exp Ther. 1998;285:1068-1072.
85. Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome: a prospective international study. Circulation. 1985;71:17-21.
86. Kligfeld P, Lax KG, Okin PM. QT interval-heart rate relation during exercise in normal men and women: defnition by linear regression analysis. J Am Coll Cardiol. 1996;28:1547-1555.
87. Y ang H, Elko P, Fromm BS, et al. Maximal ascending and descending slopes of the T wave in men and women. J Electrocardiol. 1997;30:267-276.
88. Drici MD. Infuence of gender on drug-acquired long QT syndrome. Eur Heart J. 2001;3:K41-K47.
89. Jonsson MK, Vos MA, Duker G, et al. Gender disparity in cardiac electro-physiology: implications for cardiac safety pharmacology. Pharmacol Ther. 2010;127:9-18.
90. Cheng J. Evidences of the gender-related differences in cardiac repolariza-tion and the underlying mechanisms in different animal species and human. Fundam Clin Pharmacol. 2006;20:1-8.
91. Pham T V, Robinson RB, Danilo P Jr, et al. Effects of gonadal steroids on gender-related differences in transmural dispersion of L-type calcium current. Cardiovasc Res. 2002;53:752-762.
92. Abi-Gerges N, Philp K, Pollard C, et al. Sex differences in ventricular repo-larization: from cardiac electrophysiology to Torsades de Pointes. Fundam Clin Pharmacol. 2004;18:139-151.
93. Kadish AH, Greenland P, Limacher MC, et al. Estrogen and progestin use and the QT interval in postmenopausal women. Ann Noninvasive Electrocardiol. 2004;9:366-374.
94. Fülöp L, Bányász T, Szabó G, et al. Effects of sex hormones on ECG parameters and expression of cardiac ion channels in dogs. Acta Physiol (Oxf). 2006;188:163-171.
95. Liu XK, Katchman A, Whitfeld BH, et al. In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rec-tifer potassium currents in orchiectomized male rabbits. Cardiovasc Res. 2003;57:28-36.
96. Kurokawa J, Tamagawa M, Harada N, et al. Acute effects of oestrogen on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization. J Physiol (Lond). 2008;586(Pt 12):2961-2973.
97. Rodriguez LM, de Chillou C, Schläpfer J, et al. Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol. 1992;70:1213-1215.
98. Santangeli P, di Biase L, Pelargonio G, et al. Outcome of invasive elec-trophysiological procedures and gender: are males and females the same? J Cardiovasc Electrophysiol. 2011;22:605-612.
99. Hu YF, Huang JL, Wu TJ, et al. Gender differences of electrophysiological characteristics in focal atrial tachycardia. Am J Cardiol. 2009;104:97-100.
100. Badano AR, Nagle CA, Figueroa Casas PR, et al. Plasma levels of norepi-nephrine during the periovulatory period in normal women. Further studies. Am J Obstet Gynecol. 1978;131:299-303.
101. Rosano GM, Leonardo F, Dicandia C, et al. Acute electrophysiologic effect of estradiol 17beta in menopausal women. Am J Cardiol. 2000;86:1385-7, A5.
102. Y arnoz MJ, Curtis AB. More reasons why men and women are not the same (gender differences in electrophysiology and arrhythmias). Am J Cardiol. 2008;101:1291-1296.
103. Liuba I, Jönsson A, Säfström K, et al. Gender-related differences in patients with atrioventricular nodal reentry tachycardia. Am J Cardiol. 2006;97:384-388.
104. Porter MJ, Morton JB, Denman R, et al. Infuence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm. 2004;1:393-396.
105. Suenari K, Hu YF, Tsao HM, et al. Gender differences in the clinical characteristics and atrioventricular nodal conduction properties in patients with atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol. 2010;21:1114-1119.
106. Zipes D P, Camm AJ, Borggrefe M, et al.; American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e385-e484.
107. Huang SY, Hu YF, Chang SL, et al. Gender differences of electrophysiologic characteristics in patients with accessory atrioventricular pathways. Heart Rhythm. 2011;8:571-574.
108. Liu S, Olsson SB, Hertervig E, et al. Atrioventricular conduction: a determinant for the manifestation of ventricular preexcitation in patients with Wolff-Parkinson-White syndrome. Clin Physiol. 2001;21:534-540.
109. Simonson E, Nakagawa K. Effect of age on pulse wave velocity and "aortic ejection time" in healthy men and in men with coronary artery disease. Circulation. 1960;22:126-129.
110. Timmermans C, Smeets JL, Rodriguez LM, et al. Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1995;76:492-494.
111. Chen L, El-Sherif N, Boutjdir M. Unitary current analysis of L-type Ca2+ channels in human fetal ventricular myocytes. J Cardiovasc Electrophysiol. 1999;10:692-700.
112. Liu XK, Jahangir A, Terzic A, et al. Age-and sex-related atrial electrophysi-ologic and structural changes. Am J Cardiol. 2004;94:373-375.
113. Tada H, Sticherling C, Chough S P, et al. Gender and age differences in induced atrial fbrillation. Am J Cardiol. 2001;88:436-438.
114. Roten L, Rimoldi SF, Schwick N, et al. Gender differences in patients referred for atrial fbrillation management to a tertiary center. Pacing Clin Electrophysiol. 2009;32:622-626.
115. Gerstenfeld E P, Callans D, Dixit S, et al. Characteristics of patients undergoing atrial fbrillation ablation: trends over a seven-year period 1999-2005. J Cardiovasc Electrophysiol. 2007;18:23-28.
116. Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fbrillation: the AnTicoagulation and Risk factors In Atrial fbrillation (ATRIA) study. Circulation. 2005;112:1687-1691.
117. Rienstra M, Van Veldhuisen DJ, Hagens VE, et al.; RACE Investigators. Gender-related differences in rhythm control treatment in persistent atrial fbrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol. 2005;46:1298-1306.
118. Kannel WB, Wilson PW, D'Agostino RB, et al. Sudden coronary death in women. Am Heart J. 1998;136:205-212.
119. Peters RW, Gold MR. The infuence of gender on arrhythmias. Cardiol Rev. 2004;12:97-105.
120. Vaitkus PT, Kindwall KE, Miller JM, et al. Infuence of gender on induc-ibility of ventricular arrhythmias in survivors of cardiac arrest with coronary artery disease. Am J Cardiol. 1991;67:537-539.
121. Lampert R, McPherson CA, Clancy JF, et al. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implant-able cardioverter-defbrillators. J Am Coll Cardiol. 2004;43:2293-2299.
122. Albert CM, McGovern BA, Newell JB, et al. Sex differences in cardiac arrest survivors. Circulation. 1996;93:1170-1176.
123. Chen CC, Lin CC, Lee TM. 17beta-Estradiol decreases vulnerability to ventricular arrhythmias by preserving connexin43 protein in infarcted rats. Eur J Pharmacol. 2010;629:73-81.
124. Philp KL, Hussain M, Byrne NF, et al. Greater antiarrhythmic activity of acute 17beta-estradiol in female than male anaesthetized rats: correlation with Ca2+ channel blockade. Br J Pharmacol. 2006;149:233-242.
125. Node K, Kitakaze M, Sato H, et al. Role of intracellular Ca2+ in activation of protein kinase C during ischemic preconditioning. Circulation. 1997;96:1257-1265.
126. Nakagawa M, Takahashi N, Nobe S, et al. Gender differences in various types of idiopathic ventricular tachycardia. J Cardiovasc Electrophysiol. 2002;13:633-638.
127. Rivero A, Curtis AB. Sex differences in arrhythmias. Curr Opin Cardiol. 2010;25:8-15.
128. Zareba W, Moss AJ, le Cessie S, et al. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol. 1995;26:1685-1691.
129. Locati EH, Zareba W, Moss AJ, et al. Age-and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: fndings from the International LQTS Registry. Circulation. 1998;97:2237-2244.
130. Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation. 1991;84:1136-1144.
131. Abinader EG, Shahar J. Possible female preponderance in prenylamine-induced 'torsade de pointes' tachycardia. Short communication. Cardiology. 1983;70:37-40.
132. Roden DM. Taking the "idio" out of "idiosyncratic": predicting torsades de pointes. Pacing Clin Electrophysiol. 1998;21:1029-1034.
133. Waldo AL, Camm AJ, deRuyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet. 1996;348:7-12.
134. Gowda RM, Khan IA, Punukollu G, et al. Female preponderance in ibutilide-induced torsade de pointes. Int J Cardiol. 2004;95:219-222.
135. Drici MD, Knollmann BC, Wang WX, et al. Cardiac actions of erythromycin: infuence of female sex. JAMA. 1998;280:1774-1776.
136. Woosley RL, Chen Y, Freiman J P, et al. Mechanism of the cardiotoxic actions of terfenadine. JAMA. 1993;269:1532-1536.
137. Surawicz B. Puzzling gender repolarization gap. J Cardiovasc Electro-physiol. 2001;12:613-615.
138. Wolbrette D, Patel H. Arrhythmias and women. Curr Opin Cardiol. 1999;14:36-43.
139. Clapp JF 3rd, Seaward BL, Sleamaker RH, et al. Maternal physiologic adaptations to early human pregnancy. Am J Obstet Gynecol. 1988;159:1456-1460.
140. Wolbrette D. Treatment of arrhythmias during pregnancy. Curr Womens Health Rep. 2003;3:135-139.
141. Tawam M, Levine J, Mendelson M, et al. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol. 1993;72:838-840.
142. Lee SH, Chen SA, Wu TJ, et al. Effects of pregnancy on frst onset and symptoms of paroxysmal supraventricular tachycardia. Am J Cardiol. 1995;76:675-678.
143. Nakagawa M, Katou S, Ichinose M, et al. Characteristics of new-onset ventricular arrhythmias in pregnancy. J Electrocardiol. 2004;37:47-53.
144. Brodsky M, Doria R, Allen B, et al. New-onset ventricular tachycardia during pregnancy. Am Heart J. 1992;123(4 Pt 1):933-941.
145. Rashba EJ, Zareba W, Moss AJ, et al. Infuence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation. 1998;97:451-456.
146. Seth R, Moss AJ, McNitt S, et al. Long QT syndrome and pregnancy. J Am Coll Cardiol. 2007;49:1092-1098.
147. Linde C. Women and arrhythmias. Pacing Clin Electrophysiol. 2000;23(10 Pt 1):1550-1560.